Published in Transplant Proc on June 01, 1998
Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol (1999) 1.16
Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol (2003) 1.07
Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol (2004) 0.88
A review on therapeutic drug monitoring of immunosuppressant drugs. Iran J Basic Med Sci (2011) 0.83
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. Pediatr Nephrol (2004) 0.80
Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients. Ther Drug Monit (2009) 0.78
Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients. Pediatr Nephrol (2008) 0.77
The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring. Paediatr Child Health (2002) 0.76
Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing. Pediatr Nephrol (2006) 0.75
Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease. Pediatr Rheumatol Online J (2010) 0.75
Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron (2001) 2.68
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 2.66
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol (1995) 2.14
Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08
Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg (2001) 2.02
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. Eur J Endocrinol (1997) 1.99
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyadenylylation destabilizes the rpsO mRNA of Escherichia coli. Proc Natl Acad Sci U S A (1995) 1.76
Different approaches for minimally invasive closure of atrial septal defects. Ann Thorac Surg (1999) 1.75
Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures. J Cell Biol (1989) 1.72
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Stereochemistry of polymerization by DNA-dependent RNA-polymerase from Escherichia coli: an investigation with a diastereomeric ATP-analogue. Proc Natl Acad Sci U S A (1976) 1.65
A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst (1993) 1.55
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression. Neuron (1999) 1.52
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50
Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver (1999) 1.49
Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. Arthritis Rheum (1997) 1.48
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47
Surgical treatment of cholangiocellular carcinoma. World J Surg (1995) 1.47
Involvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replication. Proc Natl Acad Sci U S A (1986) 1.47
Open heart operations after renal transplantation. Ann Thorac Surg (1997) 1.46
Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol (1990) 1.44
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43
Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart (1999) 1.43
Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction. Lancet (1990) 1.41
Matched-pair analysis of conventional versus endoluminal AAA treatment outcomes during the initial phase of an aortic endografting program. J Endovasc Ther (2000) 1.40
Pericardial flap-plasty for protection of the tracheal anastomosis in heart-lung transplantation. J Card Surg (1989) 1.40
Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted? Hepatology (1997) 1.40
Selective induction of human heat shock gene transcription by the adenovirus E1A gene products, including the 12S E1A product. Mol Cell Biol (1987) 1.40
The use of lidocaine as a test of liver function in liver transplantation. Liver Transpl Surg (1996) 1.39
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39
Preoperative corticosteroids. A contraindication to lung transplantation? Chest (1992) 1.39
Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation. Clin Chem (1997) 1.39
Development of liver size and perfusion after reduced-size liver transplantation in children. Pediatr Transplant (2001) 1.39
Generation of infectious retrovirus aerosol through medical laser irradiation. Lasers Surg Med (1998) 1.39
Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement. Ann Thorac Surg (2001) 1.39
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
Perioperative complications in combined aortic valve replacement and extraanatomic ascending-descending bypass. Ann Thorac Surg (1996) 1.36
Hepatocellular carcinoma. Br J Surg (1998) 1.35
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation (2000) 1.35
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
[Tissue adhesion with fibrin. (An experimental study with rat skin grafts) (author's transl)]. Wien Klin Wochenschr (1973) 1.28
Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys (2004) 1.28
Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med (2000) 1.28
Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology (2005) 1.26
Patterns of donor-type microchimerism after heart transplantation. Lancet (1994) 1.25
Indications for liver transplantation in hepatobiliary malignancy. Hepatology (1994) 1.23
Liver transplantation. Transplant Proc (1987) 1.23
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Integrins of normal human epidermis: differential expression, synthesis and molecular structure. Br J Dermatol (1990) 1.20
Dermal architecture and collagen type distribution. Arch Dermatol Res (1977) 1.19
Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17
Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol (1999) 1.16
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Base sequence complexity of the stable RNA species of Drosophila melanogaster. Biochemistry (1976) 1.15
Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem (2000) 1.14
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol (2001) 1.13
Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. Transplant Proc (1991) 1.13
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
Web-based training: a new paradigm in computer-assisted instruction in medicine. Int J Med Inform (1999) 1.11
Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer (2000) 1.11
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10
CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients. Clin Pharmacol Ther (2006) 1.10
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation (1996) 1.08
New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem (2000) 1.07
Update of current immunosuppressive drugs used in clinical organ transplantation. Transpl Int (1998) 1.07
Extraanatomic thoracic aortic bypass grafts: indications, techniques, and results. Eur J Cardiothorac Surg (1997) 1.05
Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol (2001) 1.05
Enzyme immunoassays in clinical chemistry: present status and trends. J Clin Chem Clin Biochem (1980) 1.04
Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem (1987) 1.04
Plasma clot welding of nerves. (Experimental report). J Maxillofac Surg (1973) 1.04